NIH-funded research R01 grant

How alcohol use affects HIV prevention medication adherence and gut health.

Official title: Alcohol Misuse, Gut Microbial Dysbiosis and PrEP Care Continuum: Application and Efficacy of SBIRT Intervention

Funded at University of Louisville · NIH-10912467 · Data updated 2026-11-12

This study is looking at how drinking alcohol might affect how well PrEP works for preventing HIV and how it can cause side effects that make it harder for people to stick to their medication, and it’s for individuals at risk for HIV who want to understand the best ways to manage their alcohol use while taking PrEP.

More PrEP research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startSeptember 10, 2022
Project endJuly 31, 2027
Funding year2024
Award (this year)$674,980
NIH project number5R01AA030485-03
Project IDNIH-10912467 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are HIV-negative individuals who are at risk for HIV and currently using or considering PrEP while also consuming alcohol.

Less likely to help

Patients who do not consume alcohol or are not at risk for HIV may not receive direct benefits from this research.

What this research studies

This research investigates the relationship between alcohol consumption and the effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV. It aims to understand how alcohol use may worsen side effects of PrEP, particularly gastrointestinal issues, and how these effects can impact adherence to the medication. The study will explore decision-making processes regarding alcohol and PrEP use among individuals at risk for HIV, and it will evaluate the effectiveness of a specific intervention (SBIRT) designed to reduce hazardous alcohol use and improve PrEP adherence. Participants will be followed over time to assess changes in their alcohol use, gut health, and adherence to PrEP.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for maintaining PrEP adherence among individuals who consume alcohol, ultimately enhancing HIV prevention efforts.

How similar studies have gone: While there is limited research specifically addressing the interaction between alcohol use and PrEP adherence, similar interventions have shown promise in improving substance use outcomes in other populations.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Researchers

  • Principal investigator: Barve, Shirish S — University of Louisville
  • Study coordinator: Barve, Shirish S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.